Cell Biology

More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital – Forbes

Synthetic biology sells picks and shovels for the $4 trillion bioeconomy, and Codon Capital sees ... [+] this opportunity. Mitchell Mutzthe accomplished venture investor, biotech serial entrepreneur, and inventorjoins Codon Capital to build a better world with biology.

Synthetic biology sells picks and shovels for the $4 trillion bioeconomy, and Codon Capital sees this opportunity. Its investments are a who's who of synthetic biology, including up-and-coming unicorns Pivot Bio, Zymergen, Bolt Threads, and more. Now, Codon Capital and its founder, Karl Handelsman, have attracted new talent. Mitchell Mutzthe accomplished venture investor, biotech serial entrepreneur, and inventorhas departed Roche Venture Fund to join Codon Capital at its San Francisco-based office.

If you follow my column, you know that synthetic biology is a fast-growing field at the forefront of manufacturing. It combines computation, automation, and our ability to read/write/edit DNA to make sustainable, high-performance products with biology. This includes better pharmaceuticals and diagnostics for Covid-19, smart drugs for cancer and diabetes, and products we dont associate with biotech like cars, sports apparel, and cell phones.

Mitchell Mutz joined Codon Capital to pursue a simple investment thesis: back great technology teams ... [+] that make the impossible possible.

Mutz has firsthand experience in this industry. He was the first employee at Labcyte, a company developing revolutionary lab equipment for scientific research, which two years ago exited with an impressive sale to Beckman Coulter for $310 million. In addition to being Labcytes first employee, Mutz also founded Amplyx Pharmaceuticals in 2007, a small molecule therapeutics company that has raised over $140 million in venture financing and recently completed a phase two clinical trial. After three and a half years as senior investment director at Roche Ventures, hes joining the Codon Capital team, focusing on therapeutics and synthetic biology.

With a Ph.D. in chemistry from the University of Rochester, experience working in midsize biotech companies, and 36 issued patents, Mutz sees himself as an investor, serial entrepreneur, and inventor. His expertise and long-time connection to Handelsman make him excited about his new role at Codon Capital.

I'm a huge synthetic biology fan. I've been thrilled beyond belief, although we didn't envision at the time how much Labcyte has become involved with being an engine for synthetic biology, says Mutz. I'm very excited to be more active in that space.

Although the economic outlook is a little more uncertain now, Handelsman sees no need to put his foot on the brake.

Karl Handelsman, founder of Codon Capital and synthetic biology investor, at SynBioBeta

Even though it is a time of turmoil, the need for early-stage innovation has never been greater, says Handelsman. This is a time when entrepreneurs and investors are stepping up to do even bolder things. It's a tough time, but its a very good time to start things. We need more innovation, and entrepreneurs have a robust desire to build out really important companies.

What does Codon Capital look for in biotech companies? In a challenging technical and economic landscape, Handelsman says Codon Capitals investment thesis is simple: We back great technical teams to make the impossible possible.

Mutz and Handelsman are not the only ones who see this young industrys potential: synthetic biology investment has topped $18 billion over the last ten years. Whether it's improving humans lives, sustaining the planet, or capitalizing on the coming bio-industrial revolution, more and more investors see synthetic biology as the ultimate enabling technology of the triple bottom line.

Follow me on Twitter at @johncumbers and @synbiobeta. Subscribe to my weekly newsletters in synthetic biology. Thank you to Stephanie Michelsen for additional research and reporting in this article. Im the founder of SynBioBeta, and some of the companies that I write about are sponsors of the SynBioBeta conference and weekly digest. Heres the full list of SynBioBeta sponsors.

Read the original:
More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital - Forbes

Cell Biology

Recursion and University of Utah launch regions largest life science incubator – Newswise

Newswise Altitude Lab announced its first resident companies and opened applications for its breakthrough collaborative facility and program. Founded by Recursion and the University of Utahs Center for Technology & Venture Commercialization (TVC), the incubator fills the critical role of finding, supporting, incubating and accelerating early-stage life science and health care companies in Utah. Altitude Lab is the first of its kinda blended incubator/accelerator program focused on developing diverse and inclusive businesses in the health care sector.

Were focused on where innovation and economic growth truly startfounders, explained Chandana Haque, executive director of Altitude Lab. We see an opportunity in Salt Lake City to propel global health care innovation by meeting the needs of a diverse community of entrepreneurs.

Altitude Lab brings together important elements to address critical gaps for founders, both in Utah and in the sector. As residents of the incubator, founders will have access to a cutting-edge 14,500-square-foot facility equipped with nearly a million dollars of the latest molecular and cell biology tools, laboratory space and modern office and networking facilities. Altitude will also offer workshops, mentoring and non-dilutive funding designed to address the opportunity gap experienced by underrepresented founders. Half of resident companies will have an underrepresented founder or executive and one third will receive grants that cover the cost of residency.

Altitude Lab is bringing together resources and a community that many startups lack, but were pivotal to Recursions success, said Chris Gibson, co-founder and CEO of Recursion. Together with the university and other partners, we can help reduce the friction of finding key assets, like lab space and capital, for a new generation of diverse companies and founders. Its an approach that we see transforming the industry in this region.

Utah is a substantial source of innovation, as TVC has launched more than two hundred companies in just the last decade, one of which was Recursion, said Keith Marmer, associate vice president for technology & venture commercialization and corporate partnerships at the U. We understand that one of greatest obstacles to building a company is finding affordable lab and office space, so Altitude Lab is providing the region with an important building block to nurture and accelerate ideas to market.

The incubators first companies include:

Altitude Lab will officially open its collaborative wet lab facility in October to enable therapeutic, diagnostic, medical device, research tools and health tech companies.

Learn more about Altitude Lab and apply for residency ataltitudelab.org.

About Altitude Lab

Altitude Lab is building a new, representative generation of founders to seed the next cycle of biotech innovation in Salt Lake City. Located in University of Utah Research Park, Altitude Lab is an incubator focused on early stage life science and health care companies. The initiative is part of alarger city planandcollaborative visionfrom Recursion and the University of Utah to foster socially-responsible entrepreneurship, job creation, and economic productivity. The Recursion Charitable Foundation, under which Altitude Lab operates, has filed for 501(c)(3) status and currently operates as a nonprofit organization. Learn more ataltitudelab.orgor connect onTwitter.

About Recursion

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology and infectious disease. Recursion applies causative perturbations to human cells to generate disease models and associated biological image data. Recursions rich, relatable database of more than 5 petabytes of biological images generated in-house on the companys robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics to radically improve lives. Recursion is headquartered in Salt Lake City. Learn more atrecursionpharma.com, or connect onTwitter,Facebook, andLinkedIn.

About the Center for Technology & Venture Commercialization

The Center for Technology & Venture Commercializationis dedicated to helping the University of Utahs faculty inventors bring their innovations to market. TVC is responsible for all aspects of invention management, patent prosecution, licensing, startup formation and support, equity management and early-stage funding. The centers mission is to generate economic returns for the university and the state of Utah, expand the universitys reputation for innovation and positively impact society. The University of Utah was recentlyrankedas the 30th-most innovative university in the world by Reuters.

Follow this link:
Recursion and University of Utah launch regions largest life science incubator - Newswise

Physiology

College of Health and Human Performance – University of Florida

August 17, 2020

Previous studies showed nitrate was helping muscles by improving use of calcium in the muscle. This finding that its additionally affecting power is significant, especially in the context of COVID-19, because the diaphragm is the primary inspiratory muscle used for breathing and coughing, the latter being relevant for clearing the lungs.

The research team at the University of Florida found that dietary nitrate supplementation elicited a pronounced increase in contractile function (power) of the diaphragm, a respiratory muscle, of old mice.

They made their measurements during maximal activation, so the effects observed seem to be caused by an improvement in the function of contractile proteins rather than calcium handling.

Few short-term interventions have such a profound impact on muscle contractile function, as was observed in this study.

Dietary nitrate is readily available for humans and could be used, under proper supervision, to improve respiratory muscle dysfunction that contributes to shortness of breath and morbidity in the elderly.

The researchers gave sodium nitrate to old mice in their drinking water daily for 14 days. The control group received regular water. Diaphragm muscle contractile function cannot be assessed directly in live animals or humans. Thus, they tested diaphragm function in muscle tissues under controlled conditions for muscle stimulation and oxygenation.

The main limitations are that mouse and human diaphragm have different percentages of fast and slow muscle cells. Mouse diaphragm consists of 90% fast muscle cells; the human diaphragm consists of 25-50% fast muscle cells depending on several factors that include and age and sex.

Dietary nitrate seems to exert a greater impact on the contractile function of fast muscle cells. Thus, the benefits to the human diaphragm may not as pronounced as was observed in mice. They also only tested male mice, and the benefits for females is unknown.

Leonardo Ferreira, Ph.D., associate professor in the Department of Applied Physiology andKinesiology and senior author on the study said:

Our findings are especially important in light of the current COVID-19 pandemic as they suggest that, if replicated in humans, dietary nitrate is useful to improve respiratory muscle dysfunction that contributes to difficulty in weaning patients from mechanical ventilation.

The article is available at physoc.onlinelibrary.wiley.com.

Read more HHP News >

Original post:
College of Health and Human Performance - University of Florida

Physiology

Acidic niche within lymph nodes plays integral role in regulating T cell activation – News-Medical.Net

In the fight against cancer, the immune system is the first line of defense. The lymphatic system specifically is essential to protecting the body against foreign invaders. Activation of immune cells in the lymph nodes leads to the production and release of antibodies, and activation of lymphocytes, including T cells, to battle infection.

But little is known about how activation of immune cells in the lymph nodes can occur without enabling effector functions that could also damage the lymphatic system.

In a new article published in Nature Communications, Moffitt Cancer Center researchers describe a novel acidic niche within lymph nodes that plays an integral role in regulating T cell activation.

Acidosis is a potent inhibitor of effector T cell functions. Oxygen levels are reported to be low in lymph nodes and that hypoxic tissue is acidic. We wanted to determine if lymph nodes were also acidic."

Robert Gillies PhD, Chair, Department of Cancer Physiology,H. Lee Moffitt Cancer Center & Research Institute

For this study, Moffitt researchers used fluorescence and magnetic resonance imaging to identify a naturally occurring acidic niche within lymph nodes. Upon further analysis, they discovered that the T cells were the source of that acidity. They say the results pinpoint localized acidosis as a critical component of the adaptive immune response.

The findings demonstrate the potential role for the lymph node microenvironment in shaping T cell biology. T cells activated by antigen-presenting cells, such as dendritic cells, produce an acidic environment that is balanced by the enhanced capacity to generate lactic acid.

"The low extracellular pH of lymph nodes does not impair the T cell's activation, but it does suppress the cytokine production, which is likely what protects lymph nodes from being attacked by the immune system," said Gillies.

The researchers say this robust physiological mechanism can be exploited by cancers, resulting in evasion of immune surveillance by malignant tissue and tumors. They believe this could be managed by manipulating the acidity in combination with immunotherapies such as T-cell checkpoint blockade therapy. However, more research is needed to confirm.

Source:

Journal reference:

Wu, H., et al. (2020) T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nature Communications. doi.org/10.1038/s41467-020-17756-7.

Originally posted here:
Acidic niche within lymph nodes plays integral role in regulating T cell activation - News-Medical.Net

Physiology

Headwall Partner Purdue Univ to Help Develop Internet of Things for Precision Agriculture – GlobeNewswire

Headwall Photonics lightweight hyperspectral UAV takes off for a flight above an experimental agricultural field.Photo courtesy geo-konzept GmbH, 2020

Bolton, MA, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Headwall Photonics, a world leader in hyperspectral imaging systems and solutions, announced today that a close technology partner, Purdue University, has been chosen by the National Science Foundation (NSF) as a key member of a new Engineering Research Center (ERC) dedicated to significant improvements in agriculture as a part of ensuring long-term food, energy, and water security.

The NSF ERC for the Internet of Things for Precision Agriculture (IoT4Ag) unites faculty and students from the University of Pennsylvania, Purdue University, the University of California at Merced, and the University of Florida with government and industry partners. Staff will utilize technology such as Headwalls hyperspectral sensors integrated onto unmanned aerial vehicle (UAV) systems to create data-driven models to capture and analyze plant physiology, soil properties, management and environmental variations.

We are excited about our partnership and we look forward to continuing our work with Headwall to maximize the impact and success of IoT4Ags technologies, education, and diversity, equity, and inclusion activities, says Melba Crawford, the Nancy Uridil and Francis Bossu Professor in Civil Engineering, and professor of agronomy and electrical and computer engineering at Purdue.

The ERC will also leverage Purdues commitment to plant science and our focus on digital agriculture. We are excited about the collaboration with our university and industrial partners to advance technology in environmental sensing, robotics, and data science in precision agriculture to help meet the demands for food production in the upcoming decades.

David Bannon, President & CEO of Headwall, is equally enthusiastic: This is one of the more prestigious and impactful partnerships that we have undertaken. A core strength of our company is providing remote-sensing solutions for customers within the agritech community. We also look forward to applying Headwall spectral imaging solutions to important problem areas to drive improved crop yield and enhanced phenotype resiliency."

About the College of Agriculture at Purdue University

Purdue Universitys College of Agriculture is one of the worlds leading colleges of agricultural, food, life, and natural resource sciences. As a land-grant institution, we are committed to preparing our students to make a difference, wherever their careers take them; stretching the frontiers of science to find solutions to some of our most pressing global challenges; and, through Purdue Extension and engagement programs, helping the people of Indiana, the nation and the world improve their lives and livelihoods.

About The NSF ERC IoT4Ag

The NSF Engineering Research Center (ERC) program supports convergent research, education, and technology translation at U.S. universities that will lead to strong societal impacts.Each ERC has interacting foundational components that go beyond the research project, including engineering workforce development at all participant stages, a culture of diversity and inclusion where all participants gain mutual benefit, and value creation within an innovation ecosystem that will outlast the lifetime of the ERC. IoT4Ag seeks to ensure food, energy, and water security with new systems to increase crop production while minimizing energy and water use and environmental impacts of agricultural practices.

About Headwall

Based in Massachusetts, Headwall is a leading designer and manufacturer of complete spectral instrumentation solutions for remote sensing, advanced machine vision, and government/defense markets. With a worldwide base of end-user and OEM customers, Headwall enjoys a market leadership position through the design and manufacture of spectral solutions that are customized for application-specific performance. With a worldwide presence, Headwall maintains offices in 3 European locations and an office in Taiwan. For more information, visitwww.headwallphotonics.com.

Originally posted here:
Headwall Partner Purdue Univ to Help Develop Internet of Things for Precision Agriculture - GlobeNewswire

Physiology

Fall 2020 classes begin at Wallace State with in-person, hybrid and online options – Cullman Times Online

The usual first-day nerves were there for some returning and new Wallace State Community College students, but for the most part, most were excited to be on campus and starting classes. While most academic classes will be taught online, technical and health science classes that require hands-on learning for skills welcomed students in hybrid classes to campus on Monday.

Emily Knighten of Falkville said she was excited but nervous to be starting her classes in the Medical Assisting program and was glad to be on campus. Im glad to be able to be here, she said. Knighten completed a short-term certificate for Medical Lab Assistant the previous semester and chose to come back to start the Medical Assistant program at the urging of coworkers at the urgent care facility where she works.

Fellow Medical Assistant student Yeniveth Benitez of Hanceville entered the program after seeing the success her sister Yadira had with it. She had a good job and she only went to school a year and a half and I wanted follow in her footsteps because shes like a mom figure to me, Benitez said. A true freshman who recently graduated from Hanceville High School, she said she was excited to be starting college classes.

Second-year Dental Hygiene student, Madisyn Bedingfield of Madison, prepped for the day by disinfecting all the surfaces of her assigned station.

Im really excited, she said. I cant wait to finish and get my license and finally get to be practicing.

Bedingfield said she appreciated everything faculty and staff did at the end of the spring semester when COVID-19 impacted their classes.

I think the faculty did a wonderful job, she said. Honestly, they had us back as soon as we could and were sending us emails and keeping us updated. Even though we had to be online, the teachers were great and really understanding in helping us as much as they could. Then we had to take our tests online. That was a challenge, but we all worked through it together.

Stephen Gholson of Springville was taking his first classes on the Hanceville campus, having previously taken classes at the Oneonta campus. Transferring from Jacksonville State University where he was a business major, Gholson is taking prerequisite courses at Wallace State to transfer to UAB to get a masters in Nursing.

So far its been a fairly easy process to get started, he said. I was able to apply and register in a total of like five days.

Collision Repair student Mario Ralius of Blountsville was returning for his third semester at Wallace State. I really enjoy the Collision Repair program, he said. Its a lot of fun. I have learned a lot and especially a lot about welding on vehicles.

Natural Science Department Chair Beth Williams was pleased with her first class of the day. Most of her Anatomy and Physiology students logged on to take part in their class and were active in asking questions through the online format, she said.

Registration is continuing for the Fall 2020 semester for Regular and Mini Term I, as well as for Flex Start Courses and Mini Term II. Registration for Flex Start I courses will be from Aug. 24-28 and from Aug. 31-Sept. 4 for Flex Start II courses. Students who register for the Flex Start courses complete those online through the end of the regular term on Dec. 16. Mini Term II courses will be held from Oct. 14 to Dec. 16.

The campus remains open for students who need to come to meet instructors, or use student services such as Lion Central, library, tutoring lab, etc. Masks and self-screening are required by all who come to campus. Support is also available virtually via http://www.wallacestate.edu/virtual-student-services.

Learn more and view a video message from Wallace State President Vicki Karolewics at wallacestate.edu/coronavirus.

We are making critical coverage of the coronavirus available for free. Please consider subscribing so we can continue to bring you the latest news and information on this developing story.

See the rest here:
Fall 2020 classes begin at Wallace State with in-person, hybrid and online options - Cullman Times Online

Neuroscience

International Project to Delve Into the Mysteries of Brain Connections – UT News | The University of Texas at Austin

AUSTIN, Texas Researchers at The University of Texas at Austin will lead an ambitious new project with 10 other U.S. institutions that has significant implications for understanding human brain health.

With support from the Next Generation Networks for Neuroscience (NeuroNex) program at the National Science Foundation (NSF), the team will examine newly discovered complexities related to synapses the tiny structures that form trillions of connections between nerve cells in the brain and allow us to think, sense, learn, act and remember. The partnership, which includes scientists in Germany, the United Kingdom and Canada, hopes to explore new ways to define what determines the strength of synapses and what alters their strength.

Traditionally, synapses have been treated as on or off switches essentially, 1-bit machines but this assumption is wrong, said Kristen Harris,a professor in the UT Department of Neuroscience and the Center for Learning and Memory, who will lead the project. Our team discovered that the information content stored in the size of a synapse can be much higher, already found to be greater than 4 bits in some brain regions. What this outcome means is that synapses are less like light switches and more like dimmer switches that can dial in the desired strength depending on need or mood.

Because new research has found synapses to be far more varied and nuanced than neuroscientists believed five years ago, the new project will examine many aspects of whats known as synaptic weight (or strength). The international scientific team will explore variation among synapses, from the level of molecules to the level of circuits, to determine what differences among them mean for our basic understanding of the brain.

Using multidisciplinary approaches, cutting-edge imaging technologies and cyber resources, the research team will generate data to predict how specific neural circuits form and function. Because recent research has uncovered the important role of differences in synaptic strength, the new project will explore how factors such as size, connectivity, volume, cellular resources and protein composition help shape these nanometer-sized structures and the effects that these differences have in the brain.

Theres still so much we dont know about how the brain works, and one of the keys to unlocking those mysteries is finding out more about specific neural circuits, said NSF NeuroNex Program Director Floh Thiels. This requires bringing together researchers from fields including chemistry, biology and computer science and engineering, and applying the latest analysis techniques to the data they produce. This has been a goal for neuroscientists for years, and what we will see from this network of researchers is a new chapter of international collaboration and coordination.

To compare and map synaptic weights the team is developing a new form of electron microscopy called tomoSEM (tomographic scanning electron microscopy), which will be able to capture information in high resolution and across large field sizes as necessary for the research. Once completed in the Harris lab, tomoSEM will be implemented and tested across labs in this NeuroNex network, and ultimately it will be standardized for general use. The images and tools will be shared with the scientific community on a public website in collaboration with UTs Texas Advanced Computing Center(TACC).

NSF has awarded more than $50 million over five years to four interdisciplinary teams, including $17.5 million for the U.S. component of the team Harris is leading. Collaborators are Alice Ting at Stanford University; Mark Ellisman at the University of California, San Diego; Erik Jorgenson and Bryan Jones the University of Utah; Clay Reid at the Allen Institute for Brain Science; Davi Bock at the University of Vermont; Narayanan Kasthuri at the University of Chicago; Linnaea Ostroff at the University of Connecticut at Storrs; Terrence Sejnowski and Uri Manor at the Salk Institute for Biological Studies; Joshua Vogelstein at Johns Hopkins University; and James Carson at TACC. In addition, Viren Jain at Google (US) will participate in this project.

Read the original post:
International Project to Delve Into the Mysteries of Brain Connections - UT News | The University of Texas at Austin

Neuroscience

A Radical New Model of the Brain Illuminates Its Wiring – WIRED

As both a clinician and a scientist, Fox is particularly interested in using the network approach not only to better understand particular diseases, but also to treat them. He has spent years working to optimize brain-stimulation treatments for diseases like Parkinsons and depression. The two primary approaches to brain stimulationdeep brain stimulation (DBS), which involves surgically implanting wires directly into the brain, and transcranial magnetic stimulation (TMS), a noninvasive approach that involves passing a magnet over specific locations on the skullwere both available when Fox began his work in the first decade of the 2000s, but they were far from being perfected.

Both technologies are based on the idea that some neurological and psychiatric diseases are caused by abnormal brain activity, and stimulation may be able to correct them. In Parkinsons, stimulating an area called the basal ganglia relieves symptoms like tremor, and a closely related technology called responsive neurostimulation can quell epileptic seizures by targeting where they originate. As an electrical engineer, the idea that you could stick electrodes in someones brain, turn them on, and have almost miracle-like effects on Parkinsons symptomsor hold an electromagnet over somebodys brain and fix their depressionit almost seemed like science fiction, he says.

But decades of research have proven that, for most other diseases, such regions dont exist. And even if they did, stimulation to a specific spot is not going to remain confined to that spot, because an activated brain region will send out signals along white matter tracts, and those signals may in turn activate other regions. If you want to stimulate [a] particular area of the brain to quiet a seizure, your stimulation to that region doesnt stay in the regionit goes everywhere else, Bassett says.

Along with giving clinicians a better understanding of the consequences of brain stimulation, network neuroscience may also help scientists design better techniques. In particular, if scientists can determine the circuits that a highly invasive technique like deep brain stimulation is acting upon, they might be able to achieve similar results with a nonsurgical approach like TMS. Once your target is a circuit, you can target that circuit in different ways, Fox says. You could begin to test the therapeutic effect of the circuit noninvasively before you do something invasive. In particular, this approach could allow clinicians to access regions buried in the brain, like those targeted in DBS treatments for Parkinsons, through areas closer to the surface. If those regions are connected to more superficial regions, then perhaps, with this network understanding, you can figure out which region is connected in the best way to the target region so that TMS will be effective, Vrtes says.

And as scientists start thinking of brain diseases as the results of multiple regions acting in concert, as opposed to single regions, they can start trying to target the whole circuit at once. It might be that the best way to help a symptom that maps to a circuit is actually multiple electrodes, or multiple stimulation sites, Fox says.

Pharmacological treatments, which dominate psychiatric practice, dont only affect specific brain areas. Just like a painkiller will lessen pain throughout the body, so too will a psychiatric medication spread throughout the brain. Nevertheless, network neuroscience could still prove useful for optimizing drug regimens: It could help clinicians target their choice of drug to the individual, not the disease. If scientists better understand what makes each brain different, they may be able to leverage those differences to predict who will respond best to which drug.

For some people, drug X works, and for some other people, drug Y works, and you dont know until you try them both, Bassett says. And I feel like its medieval science. But hopefully, with an understanding of the individual differences in the brain, we will have a better lever on how to predict human responses to a particular interventionand then not have to have people go for a year through different kinds of medication before we find one that works for them.

View original post here:
A Radical New Model of the Brain Illuminates Its Wiring - WIRED

Neuroscience

Neuroscience antibodies and assays Market is Booming Worldwide to Show Significant Growth by 2020-2026 – Owned

Neuroscience antibodies and assays Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

The data presented in the global Neuroscience antibodies and assays market report is a compilation of data identified and collected from various sources. The scope of growth of the Neuroscience antibodies and assays market during the forecast period is identified after analyzing different data sources. The report is a valuable guidance tool that can be used to increase the market share or to develop new products that can revolutionize the market growth.

Get Sample Copy of This Report: https://www.premiummarketinsights.com/sample/BRC00017587

The analysis of the collected data also helps in providing an overview of the Neuroscience antibodies and assays industry which further helps people make an informed choice. Latent growth factors that can manifest themselves during the forecast period are identified as they are key to the Neuroscience antibodies and assays market growth. The Neuroscience antibodies and assays report presents the data from the year 2020 to the year 2027 during the base period while forecasting the same during the forecast period for the year 2020 to the year 2027.

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in This Report:

Thermo Fisher Scientific, Abcam, Bio-Rad, Merck KGAA, Cell Signaling Technology, Genscript, Rockland Immunochemicals. Bio Legend, Santa Cruz Biotechnology, Tecan, F. Hoffmann-La Roche, Siemens.

To inquire about the discount available on this Report, visit @ https://www.premiummarketinsights.com/discount/BRC00017587

Global Neuroscience antibodies and assays Market by Geography:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)Europe (Turkey, Germany, Russia UK, Italy, France, etc.)North America (the United States, Mexico, and Canada.)South America (Brazil etc.)The Middle East and Africa (GCC Countries and Egypt.)

This analysis provides evaluation for altering competitive dynamics:

This thorough Neuroscience antibodies and assays analysis of this shifting contest dynamics and keeps you in front of competitions; Six-year prediction assessment primarily based mostly on the way the sector is anticipated to development; Precisely which Neuroscience antibodies and assays application/end-user kind or Types can observe incremental increase prospects; Which trends, barriers, and challenges could impact the development and size of Neuroscience antibodies and assays economy; It helps to know that the vital product-type sections along with their growth;

Fundamentals of Table of Content:

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered1.4 Market Analysis by Type1.5 Market by Application1.6 Study Objectives1.7 Years Considered

2 Global Growth Trends2.1 Neuroscience antibodies and assays Market Size2.2 Neuroscience antibodies and assays Growth Trends by Regions2.3 Industry Trends

3 Market Share by Key Players3.1 Neuroscience antibodies and assays Market Size by Manufacturers3.2 Neuroscience antibodies and assays Key Players Head office and Area Served3.3 Key Players Neuroscience antibodies and assays Product/Solution/Service3.4 Date of Enter into Neuroscience antibodies and assays Market3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product4.1 Global Neuroscience antibodies and assays Sales by Product4.2 Global Neuroscience antibodies and assays Revenue by Product4.3 Neuroscience antibodies and assays Price by Product

5 Breakdown Data by End User5.1 Overview5.2 Global Neuroscience antibodies and assays Breakdown Data by End User

Sameer JoshiCall: US: +1-646-491-9876, Apac: +912067274191Email: [emailprotected]

Premium market insightsPremiummarketinsights.comis a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Originally posted here:
Neuroscience antibodies and assays Market is Booming Worldwide to Show Significant Growth by 2020-2026 - Owned

Neuroscience

CWRU roboticist, neuroscientist to lead $8 million National Science Foundation project – Crain’s Cleveland Business

A pair of biorobotic pioneers at Case Western Reserve University will lead a five-year, $8 million National Science Foundation (NSF) project to further explore challenges scientists face in making more lifelike and responsive robots, according to a news release.

The project is part of a $50 million endeavor enlisting 70 researchers from four countries to investigate how brains work and interact with their environment. It is funded under NSF's Next Generation Networks for Neuroscience, or NeuroNex, a program that aims to establish international research networks building on existing global investments in neurotechnologies in an effort to understand the brain.

The CWRU project, "NeuroNex: Communication, Coordination, and Control in Neuromechanical Systems (C3NS)," will examine how the nervous system in animals coordinates and controls interactions with the environment, which remains a challenging research problem in neuroscience, according to the release.

Understanding animal movement is crucial for neuroscience because it has implicants for everything from eating to functioning, NSF NeuroNex program director Sridhar Raghavachari said in the release, adding that this is even more important in efforts to create a new generation of robots that can navigate difficult terrain. The C3NS project's multidisciplinary approach benefits neuroscience and robotics simultaneously, Raghavachari said in the release.

"People have been promising lifelike robots for decades and one of the reasons that we're not really there yet is really just the complexity of the world around us," said neuroscientist Hillel Chiel, a professor of biology, neurosciences and biomedical engineering in the College of Arts and Sciences, in a provided statement. "We are focused on creating autonomous devices capable of functioning in the real world, instead of redesigning the environment around them to allow them to move about."

Chiel and roboticist Roger Quinn, the Arthur P. Armington Professor of Engineering and director of the Biorobotics Complex at the Case School of Engineering, will lead the team, which also will include former CWRU researcher Vickie Webster-Wood of Carnegie Mellon, and collaborators from Northwestern University, the University of Michigan, Emory University, West Virginia University and Portland State University, the release stated. According to the NSF, international collaborators from the University of Lincoln in the United Kingdom and the University of Cologne, the University of Jena and the University of Wrzburg in Germany are funded by their home governments.

"Most roboticists try to solve problems with optimization, or with basic design solutions," Quinn said in a provided statement. "But what I've wanted to know is 'How do animals solve these problems?' It's a different way of approaching the problem and there's an animal that has solved just about every engineering problem ever."

The group's submitted plan said the project could "lead to a better understanding of the diversity of life on Earth and may suggest general organizing principles for the nervous system," according to the release. The proposal also indicates the project could also help in the investigation of motor disorders that disrupt locomotion and balance (like Parkinson's) and in the development of neurally-controlled prostheses that can effectively process human neural inputs to more naturally and effectively grasp objects or walk smoothly, according to the release.

NeuroNex is a key part of NSF's participation in the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN Initiative, a collaboration across U.S. agencies to advance the understanding of the brain. The other three projects are based at the University of Colorado, Boulder, the University of Texas, Austin, and Yale University.

"The most important questions in neuroscience are so complex they require large teams of researchers with complementary expertise," said Joanne Tornow, NSF assistant director for biological sciences, in a provided statement. "These awards will help us conquer those grand challenges and accelerate profound discoveries about how our brains work."

Link:
CWRU roboticist, neuroscientist to lead $8 million National Science Foundation project - Crain's Cleveland Business